SCHEMBL10104730

SCHEMBL10104730

CCn1c(=O)c2[nH]c(-c3cn(Cc4cccc(C)c4)nn3)nc2n(CC)c1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 18/20 0.60
ADORA1 P30542 18/20 0.60
ADORA2A P29274 17/20 0.60
ADORA3 P0DMS8 9/20 0.52
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
THPO P40225 1/20 0.51
PMP22 Q01453 1/20 0.51
HSD17B10 Q99714 1/20 0.51
PLK4 O00444 1/20 0.50
CDK2 P24941 1/20 0.50
IRAK1 P51617 1/20 0.50
RPS6KA3 P51812 1/20 0.50
PLK3 Q9H4B4 1/20 0.50
CSNK1G3 Q9Y6M4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9904195 0.87 ADORA2B (0.73) ADORA2BADORA1ADORA2AADORA3PLK4
SCHEMBL10104773 0.82 ADORA2A (0.51) ADORA2BADORA1ADORA2AADORA3
SCHEMBL1944369 0.75 ADORA2B (1.00) ADORA2BADORA1ADORA2AADORA3PLK4
SCHEMBL9903992 0.73 ADORA2B (0.72) ADORA2BADORA1ADORA2AADORA3PLK4
SCHEMBL1945592 0.73 ADORA2B (1.00) ADORA2BADORA1ADORA2AADORA3PLK4
SCHEMBL9903991 0.72 ADORA2A (0.72) ADORA2BADORA1ADORA2AADORA3PLK4
SCHEMBL1947425 0.71 ADORA2A (1.00) ADORA2BADORA1ADORA2AADORA3
SCHEMBL1944742 0.71 ADORA2B (1.00) ADORA2BADORA1ADORA2AADORA3PLK4
SCHEMBL9904021 0.71 ADORA2B (0.60) ADORA2BADORA1ADORA2AADORA3PLK4
SCHEMBL9904033 0.70 ADORA2B (0.75) ADORA2BADORA1ADORA2AADORA3PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed